apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics (2024) Haggenmüller S, Schmitt M, Krieghoff-Henning E, Hekler A, Maron RC, Wies C, Utikal JS, et al. Journal article Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning (2024) Hekler A, Maron RC, Haggenmüller S, Schmitt M, Wies C, Utikal JS, Meier F, et al. Journal article Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis (2023) Bodensohn R, Werner S, Reis J, Pazos Escudero M, Kaempfel AL, Hadi I, Forbrig R, et al. Journal article Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors (2023) Nuñez NG, Berner F, Friebel E, Unger S, Wyss N, Gomez JM, Purde MT, et al. Journal article Characterization of the impact of immune checkpoint inhibitors on platelet activation and aggregation (2023) Schlüter J, Cunningham S, Zimmermann R, Achenbach S, Kramer R, Erdmann M, Beckmann M, et al. Journal article Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: A large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases (2022) Schulz TU, Zierold S, Sachse MM, Pesch G, Tomsitz D, Schilbach K, Kähler KC, et al. Journal article Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis (2022) Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, et al. Journal article Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis (2022) Quinaglia T, Gongora C, Awadalla M, Hassan MZ, Zafar A, Drobni ZD, Mahmood SS, et al. Journal article Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life (2022) Schulz TU, Zierold S, Sachse MM, Pesch G, Tomsitz D, Schilbach K, Kähler KC, et al. Journal article Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study (2022) Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, et al. Journal article